Exelixis | 판매 및 관리 비용



Selling And Administration Expenses 변화 날짜
Acadia Pharmaceuticals USD 123.66M 2.71M 2025-06
Agios Pharmaceuticals USD 45.87M 4.34M 2025-06
Amgen USD 1.69B 4M 2025-06
AstraZeneca USD 5.01B 1.42B 2025-06
Bayer EUR 3.55B 162M 2025-06
BioMarin Pharmaceutical USD 232.28M 26.16M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Cytokinetics USD 65.72M 8.35M 2025-06
Eisai JPY 100.16B 6.34B 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Exelixis USD 134.86M 2.32M 2025-07
Genmab DKK 144M 18M 2025-06
Glaxosmithkline GBP 2.09B 609M 2025-06
Incyte USD 331.02M 5.33M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
MacroGenics USD 9.3M 18.51M 2025-06
Merck USD 2.63B 104M 2025-06
Moderna USD 230M 18M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
Novartis USD 3.44B 384M 2025-06
Pfizer USD 3.42B 406M 2025-06
Sanofi EUR 2.32B 1.08B 2025-06
Takeda JPY 255.89B 39.98B 2025-06
Ultragenyx Pharmaceutical USD 86.65M 1.15M 2025-06
Xencor USD 15.11M 2.22M 2025-06


Exelixis 판매 및 관리 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Sep 2025.